GE HealthCare advances cardiac PET diagnostics with Flyrcado launch
GE HealthCare has positioned itself at the forefront of precision cardiac diagnostics with the commercial launch of Flyrcado™ (flurpiridaz F 18) injection, marking the first new PET myocardial perfusion tracer to enter clinical practice in nearly two decades. The advanced molecular imaging agent represents a significant technological leap in coronary artery disease detection, offering clinicians […]